Authors

David S. Knopman, MD
Latest Article

The Aducanumab Saga and the Future of Antiamyloid Monoclonal Antibodies

The journey of aducanumab (Aduhelm; Biogen) from development to the FDA is a tortured one, but its path may serve to teach the Alzheimer disease field valuable lessons as it strives forward to develop disease-modifying therapies.

Atom Sarkar, MD, PhD
Latest Article

Neurosurgery and Parkinson Disease: Past, Present, and Future of Deep Brain Stimulation

Surgical care for PD is safe and effective, and should no longer be treated as a consideration of last resort, but as a treatment option discussed early in the disease course with the patient and their family.

Jason M. Schwalb, MD
Latest Article

A Team Approach to Asleep Deep Brain Stimulation

Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.

Cynthia Lemere, PhD
Latest Article

Discovering Role of Complement Activation in ARIA Risk Amid Fluid Treatment Landscape: Cynthia Lemere, PhD

The professor of neurology at Brigham and Women’s Hospital provided clinical insights on her presentation at AD/PD 2025 focusing on the emerging research surrounding complement activation and its influence on amyloid-related imaging abnormalities. [WATCH TIME: 7 minutes]

Charlyn Gomez, BS
Latest Article

Achieving Greater Diversity in Dementia Research: A Call to Action

Achieving greater diversity in study populations is a focus of increasing scrutiny, priority, and funding in all medical research, including studies enrolling individuals on the continuum of prodromal Alzheimer disease, mild cognitive impairment, and Alzheimer disease.

Jiya Desai
Latest Article

The Impact of a Social Media–Based Educational Intervention to Promote Training in Social Determinants of Health Among Medical Residents

Social determinants of health are conditions that people are born into and live under that affect their health, and can greatly impact clinical outcomes as well as contribute to health disparities and inequalities.

Claudene J. George, MD
Latest Article

Digital Health Tool Offers Innovative Quantitative Fall Assessment Solution for Older Adults

Falls cost the US more than $50 billion annually, but platforms like CatchU, a transformative digital health tool, provide quantitative fall assessment that might significantly enhance the current standard of care for predicting falls.

Elena Grebenciucova, MD
Latest Article

Bridging Neurology and Ophthalmology in Multiple Sclerosis Research

In this final episode, neurologists discuss the role of advanced imaging, like OCT, in diagnosing and managing MS, emphasizing the need for further research to optimize its clinical application. [WATCH TIME: 2 minutes]

Larry Hanover
Latest Article

Tapping Into the Potential of Cell and Gene Therapy

Advancements in gene therapy approaches have opened the door for a glimpse into the future of care for a number of diseases.

Lisa Cromer, PhD
Latest Article

Advancing Research for Cognitive Behavioral Therapy to Treat Nightmares: Lisa Cromer, PhD

The professor of psychology at the University of Tulsa discussed the clinical utility of using CBT to treat nightmares–especially in children with comorbid conditions like ADHD and anxiety–and the latest research her lab is conducting. [WATCH TIME: 4 minutes]

Robert Gross, MD, PhD
Latest Article

Expanding the Boundaries of Neurosurgical Care: Recent Advances Give Patients New Hope

Innovative neurosurgical advances in imaging/mapping, robotic assistance, and extended reality enable surgeons to more precisely and effectively treat neurological conditions such as brain tumor, epilepsy, Parkinson Disease, and stroke, giving patients new hope and a chance for more successful outcomes.

Asya Wallach, MD
Latest Article

MS Biomarkers: Overview of Current and Emerging Markers

This article reviews emerging MRI, OCT, CSF, and blood biomarkers, highlighting their potential roles in improving MS patient management and prognosis.

Smathorn Thakolwiboon, MD
Latest Article

A Case-Based Overview of Treatment Strategies for Relapse Prevention in MOGAD: Smathorn Thakolwiboon, MD

The assistant professor of neurology at Mayo Clinic College of Medicine and Science outlined a case of myelin oligodendrocyte glycoprotein antibody-associated disease from diagnosis to long-term management. [WATCH TIME: 5 minutes]

Anaya Mitchell
Latest Article

Unseen Battles: Advocacy and Community in the Face of Myasthenia Gravis

Anaya, a young woman with myasthenia gravis, discusses her challenges and triumphs living with a rare disease. She shares her personal story of advocacy and community, finding strength in the disease's impact on her independence and identity.

Alesa Monk, MBA
Latest Article

Newborn Screening Awareness Month: Understanding the Impact of Newborn Screening for SMA

Advocacy organization Cure SMA provides insight on the importance of continuing to push for standardized newborn screening and how it can positively impact outcomes in SMA.

Jonna Lorenz
Latest Article

SARS-CoV-2 May Alter Blood-Brain Barrier Function

There is no evidence yet that SARS-CoV-2 can pass the blood-brain barrier, though its effects on the barrier may be intensified in those with dementia.

Katherine Wang, MD
Latest Article

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.

G. Abbas Kharal, MD, MPH
Latest Article

Advanced Imaging for Extended Stroke Treatment

With many patients presenting with an unknown time of last known well, establishing a tissue window using advanced imaging techniques may allow for more effective intervention and better outcomes.

Gabor Toth, MD
Katelynn Getchell
Latest Article

Promising Disease-Modifying Therapies in Parkinson Disease

Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.

Becca Lassell, PhD, OTR
Latest Article

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.

Kiranpal Singh Sangha, PharmD
Latest Article

The Role of Clinical Pharmacists in Neurology: Focus on Neuroimmunology and Multiple Sclerosis Care

Kiranpal Singh Sangha, PharmD, clinical pharmacy specialist and adjunct assistant professor of pharmacy at The University of Cincinnati, talked about the vital role of clinical pharmacists in neurology, specifically in multiple sclerosis care.

Ashley Asti
Latest Article

Not Your Grandmother’s Dopamine: PMD Alliance Releases On-Demand CME Topics in Advanced Therapeutics in Movement-Related Disorders

The PMD Alliance has developed a group of 6 on-demand CME events and live panel discussions, in partnership with MedStar Georgetown University Hospital, taking place on October 23-24, 2021, developed and presented by Yasar Torres-Yaghi, MD , and Fernando Pagan, MD.

Killian Meara
Latest Article

FDA to Add Warning Related to Guillain-Barré Syndrome on Johnson & Johnson Vaccine

Since vaccine administration, the CDC has announced 100 preliminary cases of Guillain-Barré syndrome.

Neepa J. Patel, MD
Latest Article

A Team Approach to Asleep Deep Brain Stimulation

Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.

Luke Lovelace
Latest Article

Promising Disease-Modifying Therapies in Parkinson Disease

Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.

Alexa Dessy, MD
Latest Article

Addressing Constipation, Sleep, and Fatigue in Parkinson Disease Care: Alexa Dessy, MD

The clinical assistant professor in movement disorders at Jefferson Health outlined a patient-centered, lifestyle-first approach to managing Parkinson nonmotor symptoms. [WATCH TIME: 4 minutes]

Sana Aslam, DO
Latest Article

NeurologyLive® Clinician of the Month Spotlight: Sana Aslam, DO

As part of our monthly clinician spotlight, NeurologyLive® highlighted movement disorder expert Sana Aslam, DO, an assistant professor of neurology at University of Colorado School of Medicine.

Olena Bueno, RN
Latest Article

Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics 

A group of experts from The Neuron Clinic shared their experience developing a novel inclusive clinical program to treat patients with early Alzheimer disease using lecanemab.

Carla LoPinto-Khoury, MD, FAES
Latest Article

Lifting Barriers to Equitable Care in Epilepsy

Four neurologists treating patients with epilepsy share their experience in and out of the clinic tackling issues of access for their patients.
Contact Info

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us